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Abstract
Background
Pneumonia in young children is still the most frequent cause of death in developing coun-
tries. We aimed to identify predictors for recovery and treatment failure in children hospital-
ized with severe pneumonia.
Methods
We enrolled 610 Nepalese children, aged 2 – 35 months from February 2006 to June 2008.
Study participants were provided with standard treatment for pneumonia and followed up
until discharge. Three multiple regression models representing clinical variables, clinical
and radiological combined and all variables, including C-reactive protein (CRP) and viral eti-
ology were used to assess the associations.
Results
The median age of study participants was 6 months with 493 (82%) infants and 367 (61%)
males. The median time (IQR) till recovery was 49 (31, 87) hours and treatment failure was
experienced by 209 (35%) of the children. Younger age, hypoxia on admission and radio-
graphic pneumonia were independent predictors for both prolonged recovery and risk of
treatment failure. While wasting and presence of any danger sign also predicted slower re-
covery, Parainfluenza type 1 isolated from the nasopharynx was associated with earlier res-
olution of illness. Gender, being breastfed, stunting, high fever, elevated CRP, presence of
other viruses and supplementation with oral zinc did not show any significant association
with these outcomes.
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Conclusion
Age, hypoxia and consolidation on chest radiograph were significant predictors for time till
recovery and treatment failure in children with severe pneumonia. While chest radiograph is
not always needed, detection and treatment of hypoxia is a crucial step to guide the man-
agement of hospitalized children with pneumonia.
Introduction
Pneumonia is an important cause of illness and leading cause of death in young children in de-
veloping countries [1]. More than 99% of pneumonia deaths occur in low- and middle-income
countries (LMICs) [2]. The recent estimate is a median incidence of 0.22 episodes per child
year (e/cy) with severe pneumonia contributing to 11.5% in LMICs [3]. In Nepal the estimated
incidence of pneumonia is 0.24 e/cy with 11.5% severe episodes in children under 5 years of
age [3]. While several preventable risk factors for severe pneumonia in developing countries
have been identified [4] there is limited data on predictors of illness duration. Because the diag-
nosis of severe pneumonia in low income settings to a large extent relies on clinical criteria, it is
important to identify objective clinical signs at baseline that may guide subsequent manage-
ment of a severe pneumonia episode. The World Health Organization (WHO) uses evidence
based clinical guidelines for the care of sick children in hospitals of resource poor settings [5,6].
The aim of this study is to identify predictors for duration and treatment failure of WHO-de-
fined severe pneumonia in hospitalized young children in Nepal.
Methods
The study participants were recruited into a clinical trial [7] of zinc as adjuvant therapy to stan-
dard treatment of an acute episode of severe pneumonia, defined using WHO guidelines [8]
and registered at clinicaltrials.gov as NCT00252304. Clearances were obtained from the ethics
board of the Institute of Medicine, Tribhuvan University and Nepal Health Research Council,
Kathmandu. We enrolled 610 children, 2–35 months of age from February 2006 to June 2008
at the Kanti Children’s referral hospital in Kathmandu, Nepal. The Kathmandu valley lies at an
altitude of approximately 1400 meters above sea level.
Eligible children presenting to the Kanti Children’s hospital Emergency or Outpatient de-
partments were screened for enrollment by trained physicians and first assessed for hypoxemia
using a pulse oximeter (Nellcor Puritan Bennett NPB-40, Pleasanton, CA, USA) with a pediat-
ric sensor (Nellcor Pedichek D-YSPD) and for presence of wheezing. Oxygen saturation
(SpO2) was recorded twice after stabilization of the reading for one minute. The higher of the
two readings was used. For children with SpO2<90%, oxygen was provided prior to further
evaluation. This oxygen saturation of<90% was the threshold used to define hypoxia based on
WHO guidelines [8]. Children with wheezing were given up to three doses of nebulized Salbu-
tamol 15 minutes apart, reassessed and excluded if lower chest indrawing (LCI) disappeared.
History of illness was recorded and the findings of the physical examination were captured in a
standardized form. Children were weighed using an Electronic Scale 890 (SECA, Hamburg,
Germany) to the nearest 100 grams. Height in children 2 years of age or older was measured
using a standard wooden height measuring board, while recumbent length in children less than
2 years old was measured using an infantometer, both to the nearest 0.1cm. Length-for-age and
weight-for-length z scores were calculated using the 2006 WHO Child Growth Standards when
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these parameters were below-2z, the children were considered to be stunted or wasted, respec-
tively. We measured hemoglobin concentrations using Hemocue (Ångelholm, Sweden). Chest
x-rays (CXR) were taken in all children, not only to identify infiltrations, but also to detect
pleural effusion, pneumothorax or suspected heart disease, which would make a child ineligible
for the study. Children with recurrent wheezing (defined as>3 episodes over the past 6 months
and on treatment with bronchodilators), disappearance of lower chest indrawing (LCI) after
nebulized Salbutamol, severe wasting (weight-for-length<-3z), severe anemia (hemoglobin
<7 g/dL), heart disease, documented tuberculosis, concomitant diarrhea with dehydration and
those with severe illness requiring special care or surgical intervention were also excluded. We
used standardized WHO criteria to identify radiographic pneumonia [9]. The CXRs were inter-
preted independently by two radiologists blinded to clinical data, classifying findings as end-
point consolidation, other infiltrates or normal. If the two radiologists did not reach an agree-
ment on consolidation, a second round of interpretation was carried out to arrive at a consen-
sus. Informed consent was obtained for eligible children. Parents who could read and write
signed the consent statement after they had read a written statement in the local Nepali lan-
guage. For parents who were unable to read/write, verbal informed consent was obtained in the
presence of a witness, whose name and signature was recorded in a register along with the
child serial number of that particular participant. This procedure was approved by the ethics
committee for the study. After obtaining consent, blood was collected and the first dose of in-
travenous antibiotics administered. This was followed by collection of nasopharyngeal aspi-
rates for identification of 7 respiratory viruses, namely respiratory syncytial (RSV), Influenza A
and B, parainfluenza (PIV) type 1, 2, and 3, and human metapneumovirus, using a commer-
cially available multiplex reverse transcription polymerase chain reaction (PCR) assay. Details
of the sampling technique and analyses have been described elsewhere [10].
Definitions
Acute episode of severe pneumonia—A child presenting with cough (duration<14 days) and/
or difficult breathing of</ = 72 hours duration with LCI.
Time till cessation of severe pneumonia—The period starting from enrollment to the begin-
ning of a 24-hour consecutive period of absence of LCI, of hypoxia and of any danger signs.
Treatment failure—A requirement for a change in antibiotics to second line therapy in
those with failure to improve, development of complications such as empyema/pneumothorax
requiring surgical intervention or admission to the intensive care unit for ventilator and/or
inotropic support.
Failure to improve—Persistence of LCI or of any danger signs present at enrollment despite
48 hours of treatment or appearance of new danger signs or hypoxia with deterioration of a pa-
tient’s clinical status any time after initiation of treatment.
Clinical improvement—Absence of danger signs, of hypoxia for a consecutive 24-hour, and
of LCI for a 48-hour period.
Duration of hypoxia—The period from enrolment with SpO2< 90% on pulse oximetry to
the beginning of a 24 hour consecutive period of SpO2>90%, when breathing unassisted in
room air.
Enrolled children were admitted to the hospital and monitored at 8 hourly intervals by
study physicians until discharge. Benzyl penicillin (50,000 units/kg IV every 6 hourly) and
Gentamicin (7.5 mg/kg IV once daily) were given till clinical improvement, following which
children were discharged with advice to continue oral Amoxicillin to complete treatment for a
total duration of 10 days. In addition, each participant received daily supplements (dispersible
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tablets with either zinc or placebo) during their stay in the hospital and up to a maximum of
14 days [7].
Antibiotics were changed to Cefotaxime in children who did not improve. A decision to
change antibiotics was made only after consultation with senior pediatricians involved in the
study. For children unable to eat/drink or breast feed, intravenous fluids were initiated. Hu-
midified oxygen was given to children with documented hypoxia and discontinued when they
were no longer hypoxic. The absence of hypoxia was confirmed after a second reading taken 30
minutes later.
Statistical Analyses
Data were analyzed using Stata version 13 (Stata Corp, College Station, TX). We fitted multiple
regression models using clinical (Model 1), clinical and radiological (Model 2) and all (Model
3) variables. Age was used as a categorical variable. Predictors of time till cessation of a severe
pneumonia episode were identified in Cox proportional hazards models with the “exactp” op-
tion to handle ties. For treatment failure, we used logistic regression. Outcomes were coded
such that Hazard ratios (HR)<1 for time till recovery indicates slower resolution of illness and
Odds ratios (OR)> 1 increased odds of treatment failure. Initially we assessed the crude associ-
ations of relevant independent variables with the selected outcomes. Variables with p< 0.25
were included in the multivariable models and those variables which were still significant, i.e.
being associated with the outcome with a p-value of< 0. 05 retained in the model. In these
models we included the other variables one at a time and kept if significant. This manual step-
wise approach were outlined by Hosmer and Lemeshow [11].
We tested the goodness-of-fit of the models by the method suggested by Hosmer and Leme-
show [11] and for logistic regression by calculating the dfbetas and hat statistics. We assessed
the assumptions for the cox models using tests of specification (plotting of Schoenfeld residu-
als) and goodness of fit.
Results
We enrolled 610 children meeting criteria for an acute episode of severe pneumonia. We ex-
cluded from the analyses 11 children with heart disease and 1 child with chronic cough discov-
ered after inclusion. During the study, 4 of the 7 children transferred to the pediatric intensive
care unit died, 9 (1.5%) parents withdrew consent and 2 were diagnosed with tuberculosis. De-
mographic, clinical and laboratory characteristics of study participants are outlined in Table 1.
The median age of the 598 children was 6[Interquartile range (IQR) 3–10] months, 61% were
boys and 82% infants (<12 months). Mean respiratory rate [Standard deviation (SD)] was 64
(12), 62% were hypoxic and 49% had a danger sign, while 10% had 3 danger signs. On chest
auscultation, 82% of the children had wheezing and 92% had crepitations. C-reactive protein
(CRP)> 40mg/L was detected in 30%, 13% had CRP> 80mg/L. At least one virus was isolated
from 29% of the nasopharyngeal specimens; RSV being the most frequent. Radiographic pneu-
monia, defined as endpoint consolidation on chest X-ray, was detected in 164 of 457 (36%)
chest radiographs available for interpretation.
Median time (IQR) till recovery, using predefined criteria, was 49 (31, 87) hours while time
till discharge (IQR) was 97 (83, 135). Treatment failure occurred in 209 of the 594 children
(35%).
There was a near linear relationship between age and both outcomes, i.e. time till recovery
and the risk of treatment failure (data not shown). An increment in age by one month was as-
sociated with an HR of 1.04 (95% CI: 1.03–1.06) for time till recovery and the OR for treatment
failure was 0.93 (95% CI: 0.90–0.96).
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Table 1. Baseline Characteristics of children ages 2–35months with WHO defined severe pneumonia.
Background Characteristics N Value
Median age in months (IQR) 598 6 (3, 10)
Age categories
• 2–6 months (%) 352 58.9
• 7–11 months (%) 141 23.5
• 12–23 months (%) 90 15.1
• 24–35months (%) 15 2.5
Boys (%) 598 367 (61)
Breastfed (%) 598 571 (96)
Wasted (Weight for height/length Z score < -2) (%)# 594 157 (26)
Stunted (Height for age Z score <- 2) (%)# 598 50 (8)
Underweight (Weight for age Z score <- 2) (%) # 598 102 (17)
Mean age of mother (SD) 586 24.4 (4.1)
Illiterate mother (%)## 586 154 (26)
Illiterate father (%)## 588 38 (7)
Unemployed mother (%)** 584 418 (72)
Unemployed father (%)** 580 19 (3)
Clinical Characteristics
Mean Respiratory rate as breaths per minute (SD)
• 2–11 months 493 65(12)
• 12–35 months 105 61(12)
Hypoxia (SpO2 < 90%) at enrolment (%) 598 373 (62)
Febrile (Axillary temperature > 38.5°C) (%) 598 92 (15)
Danger signs (%)
-Nasal ﬂaring 597 232 (39)
-Grunting 598 131 (22)
-Head nodding 598 138 (23)
-Cyanosis 598 3 (0.5)
• Any one danger sign 598 294 (49)
• Presence of 3 danger signs 598 57 (10)
• Presence of 2 danger signs 598 96 (16)
• Presence of 1 danger sign 598 141 (24)
Wheezing (%) 598 492 (82)
Crepitations (%) 598 549 (92)
Laboratory Characteristics
Mean CRP in mg/L (SD) 572 37.9 (51.2)
-CRP > 40mg/L 572 170 (30)
-CRP > 80mg/L 572 75 (13)
Nasopharyngeal aspirate positive for any virus (%) 596 175 (29)*
-Respiratory syncytial virus (%) 596 79 (13)
-Parainﬂuenza type 1 (%) 596 23 (4)
-Parainﬂuenza type 2 (%) 596 5 (1)
-Parainﬂuenza type 3 (%) 596 24 (4)
-Inﬂuenza A (%) 596 24 (4)
-Inﬂuenza B (%) 596 17 (2)
-Human metapneumovirus (%) 596 9 (1)
Radiographic Pneumonia (%) 457 164 (36)
(Continued)
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Wasting (HR 0.79 95% CI: 0.65, 0.96), hypoxia (HR 0.62 95% CI: 0.51, 0.74) and presence of
any danger sign (HR 0.76 95% CI: 0.64, 0.91) were independently associated with slower recov-
ery (Table 2). These associations did not change substantially with the addition of other vari-
ables (Models 2 & 3). Radiographic pneumonia was also a significant predictor of delayed
recovery (HR O.58 95% CI: 0.47, 0.72). Presence of Parainfluenza type 1 (PIV 1) in the naso-
pharynx was associated with earlier recovery (HR 2.46 95%CI 1.48, 4.09). Gender, being
breastfed, stunting, high fever, CRP> 40 and>80 mg/L, presence of other viruses and supple-
mentation with oral zinc did not show any significant association with time till recovery
(Table 2).
When estimating the association between child age categories and treatment failure, the
older children had a lower risk of treatment failure (Table 3). While hypoxia and age categories
up to 23 months remained as independent predictors, the oldest age group and any danger sign
were no longer significant as indicators of treatment failure in models 2 and 3 (Table 3). Gen-
der, being breastfed, stunted, having high fever, elevated CRP, viruses in the nasopharynx, and
zinc supplementation were not significantly associated with treatment failure.
We repeated our regression analysis excluding hypoxia as a covariate in all three models
and found very little change in the hazard and odds ratios of predictors, age and radiographic
pneumonia identified earlier (data not shown). However, in the absence of hypoxia as a covari-
ate, presence of at least one danger sign was a significant predictor of treatment failure in all
models (data not shown). We also repeated the analyses using lower cut offs to define hypox-
emia i.e. SpO2 of 88% and 85% but the regression coefficients were only marginally altered
(data not shown).
We explored possible interactions between independent variables using interaction terms
(age x breastfeeding, age x wasting and age x any danger sign). Age did not modify the effect of
breastfeeding, wasting or any danger sign in any of the models.
Discussion
We report findings from secondary analyses of data from a clinical trial assessing the efficacy
of zinc in childhood pneumonia. In this large prospective study of hospitalized young Nepalese
children with acute severe pneumonia, median time till recovery of 2 days and treatment failure
in 35%, independent predictors for both outcomes were younger age, radiographic consolida-
tion and hypoxia on admission. In addition, wasting and any danger sign on admission was as-
sociated with prolonged duration of illness. With the exception of detecting PIV 1 from the
nasopharynx, which signaled earlier recovery, presence of other viruses and raised CRP levels
were not associated with either outcome. As this was a clinical trial on the efficacy of zinc in
children with severe pneumonia, we also explored the possibility of differences in the outcomes
between those who received the drug versus those who did not, and found no such interaction.
Table 1. (Continued)
Background Characteristics N Value
Supplemented with zinc (%) 598 299 (50)
# Calculated using WHO Growth standards.
*6 children were positive for 2 viruses simultaneously.
## No schooling with inability to read part or whole of a sentence.
** No work/housework.
doi:10.1371/journal.pone.0122052.t001
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While several studies report on predictors of death [12–15], we were unable to find any ex-
ploring clinical risk factors for duration of illness of a severe pneumonia episode in young chil-
dren. In our study only 4 children died in the hospital, and mortality was not an outcome.
Hypoxia, a significant predictor of death in most of the studies [12,13,15] was an independent
predictor of time till resolution of illness. While studies have identified younger children to be
at a higher risk of death [14,15], we found slower time till recovery with decreasing age
(Table 2). To our knowledge, this is the first study to identify age as an independent predictor
of the duration of severe pneumonia.
The proportions with treatment failure in large multicenter clinical trials conducted in hos-
pitalized children with severe pneumonia were 13.6% [16] and 20% [17]. These estimates are
different from our study (35%) and may partly be due to the differences in outcome definition.
Similar to the present study, hypoxia on admission was identified as an independent predictor
Table 2. Predictors of Time till Recovery of illness episode in children 2–35months hospitalized with WHO defined Severe Pneumonia.
Variables Crude Hazard Ratio* Adjusted Hazard Ratio* (number of observations)
Age in months 1.04 (1.03, 1.06) < 0.001
Age categories Model 1 (594) Model 2 (455) Model 3 (454)
• 2–6 months 1.00 1.00 1.00 1.00
• 7–11 months 1.43 (1.17, 1.75) < 0.001 1.49 (1.21, 1.83) < 0.001 1.53 (1.22, 1.94) < 0.001 1.22, 1.94) < 0.001
• 12–23 months 1.55 (1.21, 1.97) < 0.001 1.68 (1.30, 2.16) < 0.001 1.46 (1.09, 1.97) 0.012 1.09, 1.97) 0.012
• 24–35months 3.39 (2.01, 5.71) < 0.001 4.22 (2.46, 7.25) < 0.001 3.33 (1.77, 6.27) < 0.001 3.33 (1.77, 6.27) < 0.001
Gender 1.11 (0.94, 1.31) 0.223
Breastfed 0.97 (0.64, 1.47) 0.882
Wasting (< -2 Weight for height/length) 0.76 (0.63, 0.91) 0.004 0.79 (0.65, 0.96) 0.017 0.79 (0.64, 0.98) 0.030 0.78 (0.63, 0.96) 0.022
Stunting (< -2 Height/length for age) 0.84 (0.62, 1.14) 0.261
Hypoxia (SpO2 < 90%) 0.64 (0.54, 0.76) < 0.001 0.62 (0.51, 0.74) <0.001 0.71 (0.58, 0.88) 0.001 0.72 (0.58, 0.89) 0.002
Febrile (Axillary temperature > 38.5°C) 1.14 (0.91, 1.43) 0.248
Any danger sign 0.69 (0.59, 0.82) <0.001 0.76 (0.64, 0.91) 0.003 0.74 (0.60, 0.90) 0.003 0.76 (0.62, 0.92) 0.006
Radiographic pneumonia 0.56 (0.46, 0.69) <0.001 0.58 (0.47, 0.72) <0.001 0.55 (0.45, 0.68) <0.001
C-Reactive Protein (CRP) > 40 mg/L 1.01 (0.84, 1.21) 0.918
Nasopharyngeal aspirate positive for virus
• Respiratory syncytial virus (RSV) (0.62, 0.99) 0.049
• Inﬂuenza A 0.78 (0.52, 1.19) 0.252
• Inﬂuenza B (0.49, 1.33) 0.399
• Parainﬂuenza type 1 (PIV 1) 1.75 (1.14, 2.69) 0.010 2.46 (1.48, 4.09) < 0.001
• Parainﬂuenza type 2 (PIV 2) (0.40, 2.36) 0.957
• Parainﬂuenza type 3 (PIV 3) (0.96, 2.17) 0.082
• Human metapneumovirus (hMPV) 0.64 (0.32, 1.28) 0.203
Supplemented with zinc 1.11 (0.94, 1.31) 0.221
*Hazard ratios (95% CI) and P-value calculated using Cox Regression with exact p option. Hazard ratios <1 for time till recovery indicates slower
resolution of illness.
Results of multiple regressions with P-value > 0.05 not shown in the table.
Model 1 (Clinical variables): Adjusted for gender, breastfed, febrile and treatment with zinc.
Model 2 (Clinical + Radiographic pneumonia): Adjusted for gender, breastfed, febrile and treatment with zinc.
Model 3 (All variables): Adjusted for gender, breastfed, febrile, CRP, nasopharyngeal aspirate positive for RSV, inﬂuenza A and B, PIV 2 and 3 and hMPV
and treatment with zinc.
doi:10.1371/journal.pone.0122052.t002
Childhood Severe Pneumonia Predictors
PLOS ONE | DOI:10.1371/journal.pone.0122052 March 23, 2015 7 / 11
of treatment failure in both studies. The trends for age as a predictor were similar in our study
and the study by Fu. et al. [18], with younger children having a higher risk of treatment failure.
We found hypoxia to be a predictor of both treatment failure and illness duration in our
study. With hypoxia removed as a covariate, presence of any danger sign was a significant pre-
dictor of treatment failure in all three models. The variables hypoxia and any danger sign were
correlated, which is expected as both are known indicators of severe pneumonia. Clinical pre-
dictors may not be easily recognized whereas measurement of oxygen saturation with a pulse
oximeter, when performed correctly, to document hypoxia seems to be a more reliable and ob-
jective sign to assess severity. Pulse oximetry, the ‘fifth pediatric vital sign’ [19] supplemented
by treatment with oxygen was found to be a feasible and cost effective intervention for child-
hood pneumonia with 35% reduction in mortality in Papua New Guinea [20]. Unfortunately
even though pulse oximeters and oxygen are available, they are underutilized by health workers
Table 3. Predictors of Treatment failure of illness episode in children 2–35 months hospitalized with WHO defined Severe Pneumonia
Variables Crude Odds Ratio* Adjusted Odds ratio* (number of observations per model)
Age in months 0.93 (0.90, 0.96) <0.001
Age categories Model 1 (590) Model 2 (455) Model 3 (454)
• 2–6 months 1.00 1.00 1.00 1.00
• 7–11 months 0.67 (0.44, 1.01) 0.058 0.61 (0.40, 0.94) 0.024 0.56 (0.34, 0.91) 0.019 0.55 (0.34, 0.90) 0.018
• 12–23 months 0.37 (0.21, 0.64) <0.001 0.33 (0.19, 0.58)
<0.001
0.27 (0.13, 0.55)
<0.001
0.27 (0.13, 0.55)
<0.001
• 24–35months 0.22 (0.05, 0.99) 0.049 0.18 (0.04, 0.83) 0.028 0.31 (0.06, 1.54) 0.153 0.34 (0.07, 1.72) 0.194
Gender 0.83 (0.59,1.18) 0.296
Breastfed 0.67 (0.28,1.61) 0.370
Wasting (594) (< -2 Weight for height/
length)
1.49 (1.02, 2.16) 0.038
Stunting (598) (< -2 Height/Length for age) 1.25 (0.69, 2.27) 0.457
Hypoxia (SpO2 < 90%) 1.91 (1.33, 2.74) <0.001 2.00 (1.36, 2.93)
<0.001
1.80 (1.15, 2.80) 0.010 1.81 (1.16, 2.83) 0.009
Febrile (Axillary temperature > 38.5°C) 0.94 (0.59, 1.51) 0.808
Any danger sign 1.65 (1.18, 2.32) 0.004 1.44 (1.01, 2.07) 0.045
Radiographic pneumonia 2.22 (1.49, 3.31) < 0.001 2.09 (1.37, 3.19) 0.001 2.12 (1.39, 3.24) 0.001
C-Reactive Protein (CRP) > 40 mg/L 1.15 (0.79, 1.67) 0.472
Nasopharyngeal aspirate positive for virus
• Respiratory syncytial virus (RSV) 1.47 (0.91, 2.38) 0.115
• Inﬂuenza A 0.31, 1.84) 0.533
• Inﬂuenza B 0.37, 2.76) 0.989
• Parainﬂuenza type 1 (PIV 1) 0.18, 1.37) 0.178
• Parainﬂuenza type 2 (PIV 2) 0.20, 7.44) 0.819
• Parainﬂuenza type 3 (PIV 3) 0.12, 1.06) 0.063
• Human metapneumovirus (hMPV) 2.34 (0.62, 8.81) 0.209
Supplemented with zinc 0.83 (0.60, 1.17) 0.291
*Odds ratios (95% CI) and P-value calculated using Logistic Regression. Odds ratios > 1 indicates increased odds of treatment failure.
Results of multiple regressions with P-value >0.05 not shown in the table with the exception of age analyzed as a categorical variable.
Model 1 (Clinical variables): Adjusted for gender, breastfed, wasting, febrile and treatment with zinc.
Model 2 (Clinical + Radiographic pneumonia): Adjusted for gender, breastfed, wasting, febrile, any danger sign and treatment with zinc.
Model 3 (All variables): Adjusted for gender, breastfed, wasting, febrile, any danger sign, CRP, nasopharyngeal aspirate positive for RSV, PIV 1, 2 and 3,
inﬂuenza A and B, hMPV and treatment with zinc.
doi:10.1371/journal.pone.0122052.t003
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in developing countries [21,22]. Pulse oximetry to document hypoxia in community acquired
pneumonia is not only endorsed by professional societies in developed countries [23,24] but
also stated in recent WHO guidelines[6] and our findings support these recommendations.
We identified one study in India [25] reporting lobar consolidation as a predictor of longer
stay in hospital but this was based on unadjusted analysis and therefore not comparable to the
results of our study. The two studies that report an association between radiographic consolida-
tion and mortality in hospitalized children with severe pneumonia have conflicting results.
While Lupisan et al. [14] found dense infiltrates to be an independent predictor, Reed et al.
[12] report that alveolar consolidation on multiple regression analysis was not significant. Pri-
mary end point consolidation was an independent predictor of treatment failure at 48 hours of
hospitalization especially among penicillin recipients (RR 3.58 95% CI: 1.47, 8.75) in the study
by Patel et al. [17], a finding very similar to what we found. In our study, chest radiograph was
done to screen for exclusion criteria and had no role in the initial diagnosis and management
of enrolled patients. We found that addition of radiographic pneumonia to the analyses (Mod-
els 2 and 3) did not substantially change the estimates of independent clinical predictors of
both outcomes (Tables 2 and 3). In resource poor settings, diagnosis of severe pneumonia relies
heavily on clinical signs. An initial chest radiograph in uncomplicated but severe community
acquired pneumonia would not change initial management with empirical antibiotic therapy
in such settings. Our findings support the WHO guidelines [6] which state that radiographs in
severe pneumonia should be done only when possible.
We report findings from a randomized clinical trial [7] conducted under controlled settings.
Our findings may therefore not be directly applicable to other hospitals caring for children in
developing countries. We used previous WHO guidelines [8]requiring only lower chest indraw-
ing in addition to symptoms to define severe pneumonia as inclusion criteria. Although we took
measures to screen out children with reactive airways, we may have included those with pneu-
monia that could have been treated as outpatients. While recruiting, we excluded very sick chil-
dren with pneumonia and probably missed those with other signs of severe pneumonia in the
absence of LCI and this may also have affected our observed associations. While we were able to
detect several predictors for duration and treatment failure, for many of the selected indepen-
dent variables such as fever and breastfeeding, the power to detect any significant association
with the outcomes was low. It should be noted that the study was designed to measure the effect
of zinc supplementation during pneumonia and not to identify these predictors.
This large study on children aged between 2–35 months, with acute severe pneumonia found
younger age, hypoxia on admission and radiographic pneumonia to independently predict both
time to resolution and treatment failure. As it is the only study till date to report on predictors of
illness duration we believe our findings to be relevant, not only to characterize but also manage a
severe pneumonia episode in hospitalized children from resource poor settings. Our results indi-
cate that a chest radiograph is not always needed but the detection and treatment of hypoxia is a
crucial step in the management of children admitted to health care settings with pneumonia.
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